Michael Dabrowski

Michael Dabrowski, PhD, is a co-founder and the CEO of Pelago Bioscience. He has had a long career in Drug Discovery, starting first as PhD-student at Novo Nordisk and continuing as a postdoc on Type 2 diabetes. He later moved to AstraZeneca where he held a number of scientific roles within their CNS group. Through his diverse career, Michael has built a vast industry network and accumulated experience in Drug Discovery, from active laboratory activity, assay and test development, personnel manager, project management and overall portfolio responsibilities. Michael’s key strengths and experience are in establishing cross functional collaborations and Business Development.